ADHD Medications for Attention Deficit Hyperactivity Disorder (ADHD) (BAT Trial)

"This study is open to all children aged between 7 and 11 years old."

"The details of this clinical trial, which was uploaded on February 17th 2023, can be found on the website clinicaltrials.gov. It is currently in a recruitment phase and last edited its information on September 5th 2023."

"Affirmative. The clinicaltrials.gov database shows that this experiment is currently enrolling participants, with the initial post made on February 17th 2023 and the last update recorded September 5th 2023. This trial requires 30 individuals to be admitted at a single medical facility."

"This trial seeks 30 minors who are 7-11 years old and have either been diagnosed with ADHD or referred for an evaluation. These children must be seen at the Children's Hospital Primary Care Center, and cannot have tried stimulants in the past to qualify."

"Due to its status as a Phase 1 trial, indicating limited evidence of safety and efficacy, Methylphenidate Trial was assigned a score of 1."

"During the 3-week Concerta trial, this study aims to assess Long-Term Clinical Global Impressions-Improvement (CGI-I) in ADHD related impairment. Secondary endpoints include Medication Tolerance to both Concerta and Adderall XR as well as Change in Tests of Variables of Attention Commission errors on Adderall XR. To measure tolerance severity, parents' and teachers' assessments will be made using the ADHD Vanderbilt Rating scales with a summary rating from 1 (no side effects) to 2 (mild side effects) or 3 (significant side effects requiring treatment discontinuation). Additionally, TOVA"